Skip to main content
. Author manuscript; available in PMC: 2013 Aug 13.
Published in final edited form as: J Neurosurg Spine. 2011 Mar 11;14(6):742–747. doi: 10.3171/2011.1.SPINE10351

Table 1.

Age-adjusted incidence rates of primary malignant spinal cord tumor patients by variables of interest diagnosed in 1973 to 2006.

Variable of Interest No. (%) Incidence ratex 95% CIxx
OVERALL 988 (100) 0.12 (0.12,0.13)
Age at diagnosis
0–9 91 (9.21) 0.08 (0.06, 0.09)
10–19 110 (11.13) 0.09 (0.07,0.11)
20–34 238 (24.09) 0.12 (0.11,0.14)
35–49 278 (28.14) 0.17 (0.15,0.19)
50–64 180 (18.22) 0.16 (0.13,0.18)
65+ 91 (9.21) 0.10 (0.08,0.12)
Sex
 Male 557 (56.38) 0.14 (0.13,0.16)
 Female 431 (43.62) 0.11 (0.10,0.12)
Race
 White 850 (86.03) 0.13 (0.12,0.14)
 Black 86 (8.70) 0.09 (0.07,0.12)
 Other* 52 (5.26) 0.07 (0.06,0.10)
Histological type
Astrocytoma Grade I 77 (7.79) 0.009 (0.007,0.01)
Astrocytoma Grade II 31 (3.14) 0.004 (0.003,0.005)
Astrocytoma Grade II–III 26 (2.63) 0.003 (0.002,0.005)
Astrocytoma Grade III 38 (3.85) 0.005 (0.003,0.007)
GBM 39 (3.95) 0.005 (0.003,0.007)
Astrocytoma, NOS 228 (23.08) 0.03 (0.02,0.03)
Ependymoma 549 (55.57) 0.07 (0.06,0.08)
Primary Site
C70.1-Spinal meninges 6 (0.61) 0.0008 (0.0003,0.002)
C72.0-Spinal cord 964 (97.57) 0.12 (0.11,0.13)
C72.1-Cauda equina 18 (1.82) 0.002 (0.001,0.004)
x

Incidence rates are per 100,000 and age-adjusted to the 2000 US Standard Population

xx

95% Confidence interval for incidence rate.

*

American Indian/AK Native, Asian/Pacific Islander